The hotly anticipated 13th World Clinical Biomarkers & CDx Summit returns as the only industry-led meeting uniting 500+ senior decision makers in the biomarker and CDx field to accelerate clinically validated and affordable co-development of drug-CDx by overcoming commercialization, reimbursement and regulatory challenges in oncology and beyond to bring personalized medicine to patients faster.
Whether you are working in Oncology, NASH, or Neuroscience, join 600+ Directors, Heads and VPs of Clinical Biomarkers, Translational Medicine, Precision Medicine & Companion Diagnostics together with drug and diagnostic developers, regulatory experts, payors and notified bodies for an exclusive opportunity of knowledge sharing and networking to propel your pipelines and make a marked difference for patient outcomes.
Please join Dimensions at Booth E13 and for our sessions on Day 2.
Track A: Biomarker Discovery & Translational Development at 12:40 pm EST.
Challenges in Biomarker Discovery: How to Avoid Missing Information About any New Biomarker Discussed in Literature and Patents with Lauren Black, Product Solutions Manager, Dimensions.
Synopsis: Perform complex and time-consuming scientific literature analysis in a real time! Discover all proteins related to your specific disease setting. Get comprehensive insights driven by the biggest protein ontology in the field (more than 6M concepts and synonyms). Get aware about new biomarkers discussed in patents but not literature yet, and vice versa.
